Avantor, Inc. Operating Cash Flow
Avantor, Inc. (AVTR) reported Operating Cash Flow of $58.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-29
- Avantor, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $58.70M, a 46.29% decline year-over-year.
- Avantor, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $152.70M, a 11.89% decline year-over-year.
- Avantor, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $207.40M, a 15.28% decline year-over-year.
- Avantor, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was $154.40M, a 45.07% decline year-over-year.
- Avantor, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $623.80M, a 25.81% decline from fiscal 2024.
- Avantor, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $840.80M, a 3.36% decline from fiscal 2023.
- Avantor, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $870.00M, a 3.13% increase from fiscal 2022.
- Avantor, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $843.60M, a 11.54% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | $58.70M 10-Q · filed 2026-04-29 | $211.40M derived: sum of 2 quarters · filed 2026-04-29 | $418.80M derived: sum of 3 quarters · filed 2026-04-29 | $573.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $152.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $360.10M derived: sum of 2 quarters · filed 2026-02-11 | $514.50M derived: sum of 3 quarters · filed 2026-02-11 | $623.80M 10-K · filed 2026-02-11 |
| 2025-09-30 | $207.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $361.80M derived: sum of 2 quarters · filed 2025-10-29 | $471.10M 10-Q · filed 2025-10-29 | $644.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $154.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $263.70M 10-Q · filed 2025-08-01 | $437.00M derived: sum of 3 quarters · filed 2026-04-29 | $681.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $109.30M 10-Q · filed 2026-04-29 | $282.60M derived: sum of 2 quarters · filed 2026-04-29 | $527.40M derived: sum of 3 quarters · filed 2026-04-29 | $808.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $173.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $418.10M derived: sum of 2 quarters · filed 2026-02-11 | $699.20M derived: sum of 3 quarters · filed 2026-02-11 | $840.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $244.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $525.90M derived: sum of 2 quarters · filed 2025-10-29 | $667.50M 10-Q · filed 2025-10-29 | $919.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $281.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $422.70M 10-Q · filed 2025-08-01 | $674.30M derived: sum of 3 quarters · filed 2026-02-11 | $905.00M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $141.60M 10-Q · filed 2025-04-25 | $393.20M derived: sum of 2 quarters · filed 2026-02-11 | $623.90M derived: sum of 3 quarters · filed 2026-02-11 | $792.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $251.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $482.30M derived: sum of 2 quarters · filed 2026-02-11 | $650.50M derived: sum of 3 quarters · filed 2026-02-11 | $870.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | $230.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $398.90M derived: sum of 2 quarters · filed 2024-10-25 | $618.40M 10-Q · filed 2024-10-25 | $824.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $168.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $387.70M 10-Q · filed 2024-07-26 | $593.30M derived: sum of 3 quarters · filed 2025-02-07 | $851.60M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $219.50M 10-Q · filed 2024-04-26 | $425.10M derived: sum of 2 quarters · filed 2025-02-07 | $683.40M derived: sum of 3 quarters · filed 2025-02-07 | $910.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $205.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $463.90M derived: sum of 2 quarters · filed 2025-02-07 | $691.40M derived: sum of 3 quarters · filed 2025-02-07 | $843.60M 10-K · filed 2025-02-07 |
| 2022-09-30 | $258.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $485.80M derived: sum of 2 quarters · filed 2023-10-27 | $638.00M 10-Q · filed 2023-10-27 | $939.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $227.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $379.70M 10-Q · filed 2023-07-28 | $680.70M derived: sum of 3 quarters · filed 2024-02-14 | $942.60M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $152.20M 10-Q · filed 2023-04-28 | $453.20M derived: sum of 2 quarters · filed 2024-02-14 | $715.10M derived: sum of 3 quarters · filed 2024-02-14 | $978.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $301.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $562.90M derived: sum of 2 quarters · filed 2024-02-14 | $826.70M derived: sum of 3 quarters · filed 2024-02-14 | $953.60M 10-K · filed 2024-02-14 |
| 2021-09-30 | $261.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $525.70M derived: sum of 2 quarters · filed 2022-10-28 | $652.60M 10-Q · filed 2022-10-28 | $958.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $263.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $390.70M 10-Q · filed 2022-07-29 | $696.70M derived: sum of 3 quarters · filed 2023-02-14 | $978.20M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $126.90M 10-Q · filed 2022-04-29 | $432.90M derived: sum of 2 quarters · filed 2023-02-14 | $714.40M derived: sum of 3 quarters · filed 2023-02-14 | $803.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $306.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $587.50M derived: sum of 2 quarters · filed 2023-02-14 | $676.70M derived: sum of 3 quarters · filed 2023-02-14 | $929.80M 10-K · filed 2023-02-14 |
| 2020-09-30 | $281.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $370.70M derived: sum of 2 quarters · filed 2021-10-29 | $623.80M 10-Q · filed 2021-10-29 | $710.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $89.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $342.30M 10-Q · filed 2021-07-30 | $429.30M derived: sum of 3 quarters · filed 2022-02-11 | $627.20M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $253.10M 10-Q · filed 2021-04-28 | $340.10M derived: sum of 2 quarters · filed 2022-02-11 | $538.00M derived: sum of 3 quarters · filed 2022-02-11 | $532.10M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $284.90M derived: sum of 2 quarters · filed 2022-02-11 | $279.00M derived: sum of 3 quarters · filed 2022-02-11 | $354.00M 10-K · filed 2022-02-11 |
| 2019-09-30 | $197.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $192.00M derived: sum of 2 quarters · filed 2020-10-27 | $267.00M 10-Q · filed 2020-10-27 | $336.90M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$5.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $69.10M 10-Q · filed 2020-07-29 | $139.00M derived: sum of 3 quarters · filed 2021-02-16 | $247.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $75.00M 10-Q · filed 2020-04-29 | $144.90M derived: sum of 2 quarters · filed 2021-02-16 | $253.10M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | $69.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $178.10M derived: sum of 2 quarters · filed 2021-02-16 | $200.50M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $108.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $130.60M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $22.40M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | -$167.50M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |